Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Grade Last Price % Change Price Change
grade C 2.26 -9.24% -0.23
CANF closed down 9.24 percent on Wednesday, August 5, 2020, on approximately normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical CANF trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
200 DMA Support Bullish 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -9.24%
NR7 Range Contraction -9.24%
Inside Day Range Contraction -9.24%
Wide Bands Range Expansion -9.24%
Up 3 Days in a Row Strength -9.24%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.
Medicine Biotechnology Cancer Medical Specialties Immunology Treatment Of Cancer Rheumatoid Arthritis Psoriasis Glaucoma Inflammatory Diseases Arthritis Hepatocellular Carcinoma Immunosuppressants Uveitis Biotie Therapies Treatment Of Inflammatory Diseases Treatment Of Psoriasis

Is CANF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.95
52 Week Low 1.08
Average Volume 1,773,332
200-Day Moving Average 2.15
50-Day Moving Average 2.04
20-Day Moving Average 2.24
10-Day Moving Average 2.43
Average True Range 0.24
ADX 49.23
+DI 31.50
-DI 19.26
Chandelier Exit (Long, 3 ATRs ) 2.24
Chandelier Exit (Short, 3 ATRs ) 2.46
Upper Bollinger Band 2.73
Lower Bollinger Band 1.75
Percent B (%b) 0.52
BandWidth 43.69
MACD Line 0.13
MACD Signal Line 0.13
MACD Histogram -0.0047
Fundamentals Value
Market Cap 39.23 Million
Num Shares 17.4 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -4.43
Price-to-Sales 132.22
Price-to-Book 7.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.97
Resistance 3 (R3) 2.97 2.74 2.85
Resistance 2 (R2) 2.74 2.56 2.74 2.81
Resistance 1 (R1) 2.50 2.45 2.39 2.50 2.77
Pivot Point 2.27 2.27 2.21 2.27 2.27
Support 1 (S1) 2.03 2.09 1.92 2.03 1.75
Support 2 (S2) 1.80 1.98 1.80 1.71
Support 3 (S3) 1.56 1.80 1.67
Support 4 (S4) 1.56